Connect with us

Government

What’s Up with the FDA’s Delay on CBD Rules? (2022 Update)

Published

on

When will the FDA get around to doing what they said on CBD?

The hemp industry was shocked to its core when the 2018 Farm Bill passed. It’s not that the changes hadn’t been expected. In 2014, a similar bill was signed into law that started the process of re-legalizing hemp.

The possibilities were just suddenly staggeringly enormous. With “industrial hemp” CBD products containing less than 0.3% THC now essentially legal in all 50 states, the hemp market found itself with ample room to grow.

Over the last year or so, though, hemp industry stakeholders have started to feel themselves hit something of a wall. Comprehensive regulation issued by the FDA (CBD’s new federal overseer) has been expected since 2020 but still hasn’t arrived, leading to a general sense of uneasiness.

The pandemic slowed things down, but there are other factors at play here as well. Find out exactly why it’s 2022 already and the FDA still hasn’t properly regulated CBD.

The Current Status of CBD

Under the 2018 Farm Bill, most hemp-extracted CBD products containing less than 0.3% delta-9 THC are considered industrial hemp, a legal category that is entirely separate from the Controlled Substances Act’s definition of “marijuana”. As a result, CBD oil for pain and a vast variety of other CBD products are now sold widely on the internet and shipped to all 50 states.

CBD is not exactly legal in the sense of an over-the-counter drug, a supplement, or even a prescription drug in the majority of cases. The DEA may no longer have any jurisdiction over CBD, but for the most part, the FDA has failed to pick up the reins.

The FDA’s Position

In June of 2022, hopes briefly surged that the FDA might be getting close to releasing some definitive CBD guidance. The federal agency announced that it would be convening its Science Board to discuss the challenges related to regulating cannabinoids as dietary supplements or food ingredients.

Before it even took place, though, industry insiders were already confident that this meeting wouldn’t result in any major changes to the status quo of CBD regulation in the United States. Recent FDA statements make it clear that the agency is facing significant challenges as it develops regulatory frameworks that properly encompass CBD as an easily accessible online ingredient.

The FDA has at least one legitimate reason for taking its time on CBD: There’s still a serious lack of definitive safety data regarding the cannabinoid itself and the types of products in which it is commonly included. The FDA has commissioned various studies to determine the CBD’s safety, but it takes a while for that sort of research to come in.

Lack of safety data isn’t the only factor holding the FDA back, though. A decision the agency made regarding CBD back in 2018 has returned to haunt it in the here and now.

The Epidiolex Dilemma

Epidiolex is a CBD-based prescription drug developed by UK cannabis giant GW Pharmaceuticals. The FDA approved Epidiolex in 2018 for certain types of intractable epilepsy (including Dravet syndrome) and has since expanded the CBD drug’s accepted uses.

Though it’s called a “CBD-based drug” in regulatory contexts, the sole active ingredient in Epidiolex is hemp-derived CBD: The same hemp-derived CBD, for all intents and purposes, as you can find in hemp products sold on the internet.

The FDA has a long-standing precedent of not approving substances as supplements or over-the-counter drugs after they’ve already been approved as prescription medications. Though additional variables, such as federal cannabis legislation, may also sway the FDA’s decision on the matter, the fact that CBD is available on a prescription basis in Epidiolex is making it very hard for the agency to approve or regulate the cannabinoid in other contexts.

Possible Solutions on the Horizon

In May of 2022, the Democrat-controlled US House of Representatives passed a bill that would remove cannabis from the Controlled Substances Act. If the bill carries through the Senate and reaches the President’s desk, it could be the trigger the FDA needs to finally resolve the paradoxes surrounding federal CBD regulation.

Due to considerable political failures since gaining the majority in 2020, though, it’s possible the House and Senate will return to Republican control during the midterm federal elections, potentially stalling cannabis reform. Over time, ongoing research regarding CBD’s safety will continue to come in, and the FDA will eventually resolve regulatory conflicts between Epidiolex and other forms of CBD. The near future of the American hemp industry remains murky, however.

Summary: When Will the FDA Move on CBD?

In mid-2019, practically every industry expert predicted that comprehensive federal cannabis reform — accompanied by FDA clarity on CBD — would arrive in 2020. Then, the pandemic hit, and non-essential federal government activity was mostly shut down.

Now, political ambiguity is combining with regulatory tangles that are harder than expected to solve, making the exact path American CBD takes from here unsettlingly uncertain. What we know for sure, though, is that CBD industry leaders are committed to building a better tomorrow for hemp one day at a time.

Source: https://cannabis.net/blog/news/whats-up-with-the-fdas-delay-on-cbd-rules-2022-update

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Corruption

Four Ganga Land Leases Cancelled in Sambhal After Record Irregularities

Published

on

By

The Sambhal district administration has cancelled four government land leases issued more than three decades ago after an official investigation found alleged irregularities in the classification and allotment of Ganga river land.

The action follows an inquiry that concluded approximately 31 bigha of land in Surpur village of Gunnour tehsil was leased after its original revenue classification was allegedly altered, allowing land categorized as riverbed to be treated as agricultural property.

Inquiry Reveals Alleged Record Manipulation

The decision was taken by the Additional District Magistrate (ADM) based on an investigation conducted by the Sub-Divisional Magistrate (SDM), Gunnour.

Officials found that while the current revenue records listed the land as transferable agricultural property, older consolidation documents identified it as Category-6(1) submerged river land, making it ineligible for such allotments.

Following the findings, the administration ordered the cancellation of all four leases and directed revenue officials to restore the land’s original classification in official records.

Leases Issued in 1991 Declared Invalid

According to the inquiry, the disputed leases were granted on November 17, 1991, in the names of Shrinivas, Sher Singh, Shakuntala, residents of Surpur village, and Prakash Chandra of Patei Kayasth village.

Authorities stated that the allotments did not comply with the provisions of Section 128 of the Uttar Pradesh Revenue Code, 2006, prompting their cancellation.

Officials said corrective entries are now being made in the revenue records to reflect the land’s original legal status.

Wider Probe Into Ganga Riverbank Land Allotments

The latest action is part of a broader investigation into alleged irregularities involving government land located along the Ganga riverbank in Sambhal district.

Earlier investigations uncovered suspected illegal allotments involving nearly 845 bigha of government land in Sukhailla village under Gram Panchayat Asadpur, where 162 leases are also under scrutiny.

Investigators believe a similar pattern may have been followed in multiple cases, with riverbed land allegedly reclassified as agricultural land before being leased to individuals.

Field inspections reportedly found that much of the land was unsuitable for conventional farming and was instead being used for activities such as sand mining.

Government Land Worth ₹18 Crore Under Review

District officials estimate that approximately 850 bigha (around 71.5 hectares) of government land, valued at nearly ₹18 crore, is currently under investigation.

Authorities have launched a comprehensive review of historical land leases issued across villages situated along the Ganga river in the Rajpura, Gunnour, and Junawai blocks.

The objective is to determine which allotments were made legally and identify cases where land records may have been manipulated.

Officials’ Role Also Being Examined

The investigation has also raised questions about the possible involvement or negligence of officials from the revenue and consolidation departments.

District authorities said responsibility will be fixed after the inquiry is completed, and legal or departmental action will be taken against anyone found to have violated land allotment rules.

Officials indicated that the ongoing review could reveal additional cases involving unauthorized occupation or irregular leasing of government land.

The administration has reiterated its commitment to restoring government property and ensuring transparency in land management across the district.

Continue Reading

Education & Training

NTA Warns NEET UG 2026 Candidates Against Fake OMR Sheets

Published

on

By

The National Testing Agency (NTA) has issued a warning to NEET UG 2026 candidates and their parents against submitting fake, altered, or AI-generated OMR sheets while raising objections related to examination results.

The examination authority said that candidates found providing fabricated documents or misleading information during the verification process could face legal consequences.

The warning comes after several students approached the agency with complaints alleging discrepancies between their expected scores and the marks published in the final results.

NTA Finds Suspicious Documents During Verification

According to the NTA, some candidates submitted OMR sheets while requesting score verification, but officials found that certain documents appeared to be manipulated or artificially generated.

The agency clarified that only original OMR sheets issued during the examination process will be accepted for reviewing complaints.

NTA officials said they are examining all grievances carefully and will consider only verified examination records while deciding on score-related concerns.

Students Raise Questions Over NEET UG Results

After the announcement of NEET UG 2026 results, several candidates reported differences between their estimated marks based on the official answer key and their final scorecards.

Some students claimed that their expected scores were significantly higher than the marks awarded in the results.

In some reported cases, candidates alleged that uploaded OMR sheets did not match their original answer sheets or that the displayed scores were inconsistent with their calculations.

The complaints prompted several students and parents to seek clarification and request a detailed review of the evaluation process.

AI-Generated Fake Records Create New Challenge

The NTA has highlighted the growing misuse of artificial intelligence tools to create fake examination documents.

Officials said digitally altered OMR sheets and fabricated records could create difficulties in identifying genuine grievances and may affect the integrity of the complaint resolution system.

The agency advised candidates to avoid using unofficial documents or modified materials while submitting objections.

Candidates found involved in producing false evidence may face action under applicable laws, the NTA warned.

NEET UG 2026 Conducted Again After Paper Leak Allegations

The NEET UG 2026 examination process faced controversy after allegations of a paper leak led authorities to cancel the original exam held on May 3.

A re-examination was conducted on June 21 for affected candidates, following which results were announced on July 16.

After the controversy, the government announced plans to move future NEET UG examinations from the traditional pen-and-paper format to a computer-based testing (CBT) system.

Verification Process Continues

The NTA said the review of complaints submitted by candidates is still underway and further decisions will be taken after completing the verification of all documents.

The agency has urged students to rely only on official communication channels and submit genuine records while seeking clarification about their results.

Continue Reading

Corruption & Governance

Goa PWD Tenders Worth ₹1,000 Crore Come Under Government Probe

Published

on

By

The Goa government has initiated a detailed investigation into alleged irregularities in Public Works Department (PWD) tenders worth nearly ₹1,000 crore, following complaints of document manipulation and misuse of contractor eligibility credentials.

The probe focuses on claims that certain construction firms may have secured high-value infrastructure contracts by submitting falsified or altered work completion certificates to qualify for top contractor categories.

Allegations of Fake Experience Certificates in Tender Bids

According to complaints filed by engineers and contractors, several companies allegedly used questionable documentation to obtain Class IAA contractor status, a designation that allows participation in large-scale government infrastructure projects.

Investigators are examining whether manipulated work completion certificates were used to falsely demonstrate prior project experience, thereby inflating eligibility during the tender evaluation process.

One of the key concerns involves references to infrastructure projects executed under Karnataka Neeravari Nigam Limited, including the “Mudi Tank Filling Scheme.” Authorities are verifying claims that duplicate or inconsistent completion certificates may have been issued for the same project.

JV Structure Alteration Under Scrutiny

Officials are also investigating alleged changes in joint venture (JV) agreements submitted during tender applications. In one case under review, a 2019 JV reportedly listed Amrita Constructions Private Limited as the lead partner, with another firm as a supporting entity.

However, documents submitted to Goa PWD allegedly reversed these roles, naming Bagkiya Constructions as the lead partner. This change is suspected to have significantly enhanced the company’s technical eligibility and past performance record.

Authorities believe such alterations may have allowed firms to qualify for contracts they would otherwise not have been eligible for under standard procurement norms.

Allegations Linked to Karnataka Project Documentation

Another complaint under review concerns the “Akka Mahadevi Memorial Project” in Shivamogga, Karnataka, valued at over ₹51 crore. It is alleged that the project, executed in phases, was incorrectly represented as a single completed contract to meet eligibility requirements for higher-value tenders.

Investigators are verifying whether such representations were used to gain unfair advantage in experience-based qualification criteria.

Government Launches Comprehensive Inquiry

Following the emergence of these allegations, the Goa government has ordered a preliminary inquiry into all related contracts, approvals, and supporting documentation.

Officials have stated that every stage of the tendering process—including eligibility checks, certificate validation, and contract award decisions—will be examined in detail.

If irregularities are established, possible actions may include contract cancellation, blacklisting of firms, recovery of funds, and legal proceedings against those involved in submitting false documentation.

Concerns Over Procurement Transparency

The case has raised broader concerns about transparency and verification systems in public infrastructure procurement. Experts point out that reliance on manual documentation without robust digital verification increases the risk of fraud in large-scale government contracting.

Transparency advocates have called for stronger auditing systems, centralized contractor databases, and real-time verification of project credentials to prevent misuse of public tender processes.

Probe Continues

Authorities have confirmed that the investigation is ongoing and a detailed report will be prepared after reviewing all evidence and documentation. Further action will be taken based on the findings in accordance with applicable laws and procurement rules.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News